Table 5

Overall and progression free survival.

Total

OS

Median

> 20 months

6 month

89.5%

12 month

83.4%

PFS

Median

(months, 95% CI)

12.1

(8.4-15.8)

6 month

80.3%

12 month

51.8%

Ardavanis et al. BMC Cancer 2009 9:338   doi:10.1186/1471-2407-9-338